Therapiva is committed to provide high quality Pharmaceutical products to the customers. To meet this commitment, we have implemented current good manufacturing practice requirements across all development & manufacturing sites, encompassing all areas of business processes & throughout the supply chain.
The quality management systems applicable to API process development, analytical development & testing, contract research & development, and manufacture of pharmaceutical products, meet the current requirements of global regulation. Therapiva envisages to meet & excel the current requirements of GxPs and undergo audits by global regulatory agencies during the year 2020 & onwards.
Therapiva envisages to have a reputation of on time delivery of high quality APIs to the global pharmaceutical community. Therapiva functions with a proactive outlook on anticipated global regulations and adapt readily to dynamic environment to ensure business continuity